Abbott will be supplying COVID-19 antibody tests to India


2020-06-22 17:30:25



US-based healthcare technology maker Abbott on Monday said it can supply over one million of its laboratory-based serology blood test for the detection of the antibody, IgG (Immunoglobulin G), that identifies if a person has had the novel coronavirus (COVID-19).

Abbott said it is already in the process of delivering antibody tests to leading government and private hospitals and labs in Maharashtra, Delhi, West Bengal, Uttar Pradesh, Jammu and Kashmir and Gujarat.

Abbott's SARS-CoV-2 IgG test specifically identifies the IgG antibody, which is a protein that the body produces in the late stages of infection and may remain for up to months and possibly years after a person has recovered.